We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anticaries Potential and Fluorosis Risk From Different Fluoride Toothpastes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01589991
Recruitment Status : Completed
First Posted : May 2, 2012
Last Update Posted : October 28, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Fluoride toothpaste has been associated not only with declining dental caries prevalence but also with an increase in dental fluorosis. In the balance of benefits/risks of fluoride toothpaste use, the purpose of this study is to evaluate the availability of fluoride concentration in the mouth (biofilm fuild), as an indicator of fluoride benefits (anticaries effect), and the fluoride concentration in urine, as an indicator of fluoride absorption from ingested toothpastes (with potential to cause dental fluorosis), in a sample of young Brazilian children using toothpaste formulations representative of those available and most used by this age-group.

Condition or disease Intervention/treatment Phase
Dental Caries Dental Fluorosis Drug: Toothpaste Phase 1

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Official Title: Anticaries Potential and Fluorosis Risk From Different Fluoride Toothpastes
Study Start Date : January 2011
Primary Completion Date : December 2012
Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tooth Decay
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Placebo Comparator: Non-fluoride toothpaste Drug: Toothpaste
The volunteers brushed their teeth with 0.3 g of the assigned toothpastes, 3x/day.
Experimental: Toothpaste 550 µg F/g (NaF/SiO2) Drug: Toothpaste
The volunteers brushed their teeth with 0.3 g of the assigned toothpastes, 3x/day.
Experimental: Toothpaste 1100 µg F/g (NaF/SiO2) Drug: Toothpaste
The volunteers brushed their teeth with 0.3 g of the assigned toothpastes, 3x/day.
Experimental: Toothpaste 1450 µg F/g (MFP/CaCO3) Drug: Toothpaste
The volunteers brushed their teeth with 0.3 g of the assigned toothpastes, 3x/day.


Outcome Measures

Primary Outcome Measures :
  1. Fluoride concentration in biofilm fluid [ Time Frame: 30min ]
    Remants of dental plaque (biofilm) will be collected 30 min after brushing with the toothpastes, the fluid will be separated from the solids by centrifugation and the fluoride concentration in the biofilm fluid will be determined by a fluoride electrode adapted for microanalysis.

  2. Urinary fluoride excretion [ Time Frame: 8h ]
    Urine will be collected at two time-points, either before the use of the toothpaste or at the last day of use, in each experimental phase. Fluoride concentration was determined by an inverted ion-specific fluoride electrode and fluoride excretion will be measured by fluoride/cratinine ratio (mg F/mg creatinine).


Secondary Outcome Measures :
  1. Fluoride concentration in biofilm solid [ Time Frame: 30min ]
    Remants of dental plaque (biofilm) will be collected 30 min after brushing with the toothpastes, the fluid will be separated from the solids by centrifugation and the fluoride concentration in the biofilm solids will be determined after acid extraction using a fluoride electrode adapted for microanalysis.

  2. Fluoride concentration in saliva [ Time Frame: 30min ]
    Non-stimulated saliva will be collected at 0 (immediately before toothbrushing), 7, 15 and 30 min after toothbrushing. Fluoride concentration in saliva will be determined by a ion-specific fluoride electrode, adapted for microanalysis.

  3. Amount of toothpaste ingested [ Time Frame: January 2013 to July 2013 ]
    Determination of amount of toothpaste ingested after one simulated brushing.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 4 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Good general health
  • Good oral health
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01589991


Locations
Brazil
Piracicaba Dental School, University of Campinas
Piracicaba, Sao Paulo, Brazil, 13414903
Sponsors and Collaborators
University of Campinas, Brazil
Investigators
Study Chair: Livia MA Tenuta, PhD Piracicaba Dental School, University of Campinas
More Information

Publications:

Responsible Party: Livia Maria Andaló Tenuta, Assistant Professor, Biochemistry and Cariology, University of Campinas, Brazil
ClinicalTrials.gov Identifier: NCT01589991     History of Changes
Other Study ID Numbers: FOPBioq002
First Posted: May 2, 2012    Key Record Dates
Last Update Posted: October 28, 2013
Last Verified: October 2013

Keywords provided by Livia Maria Andaló Tenuta, University of Campinas, Brazil:
toothpastes
bioavailability
sodium fluoride
monofluorphosphate
low-fluoride

Additional relevant MeSH terms:
Dental Caries
Fluoride Poisoning
Fluorosis, Dental
Tooth Demineralization
Tooth Diseases
Stomatognathic Diseases
Poisoning
Chemically-Induced Disorders
Fluorides
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs